COMMON STOCK PURCHASE WARRANT B cellectar biosciences, inc.Common Stock Purchase Warrant • July 22nd, 2024 • Cellectar Biosciences, Inc. • Pharmaceutical preparations • New York
THIS COMMON STOCK PURCHASE WARRANT (the “Warrant”) certifies that, for value received, _____________ or its assigns (the “Holder”) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the date hereof (the “Initial Exercise Date”) and on or prior to 5:00 p.m. (New York City Time) on the Termination Date but not thereafter, to subscribe for and purchase from Cellectar Biosciences, Inc., a Delaware corporation (the “Company”), up to ______ shares (as subject to adjustment hereunder, the “Warrant Shares”) of Common Stock; provided however, that, in lieu of Warrant Shares, such Holder may elect to receive pre-funded common stock purchase warrants in lieu of some or all Warrant Shares in the form set forth on Exhibit C hereto (the “Pre-Funded Warrants”), if at the time of exercise, the Holder or its Affiliates would beneficially own in excess of the Beneficial Ownership Limitation (as defined below), in which
COMMON STOCK PURCHASE WARRANT C cellectar biosciences, inc.Common Stock Agreement • July 22nd, 2024 • Cellectar Biosciences, Inc. • Pharmaceutical preparations • New York
THIS COMMON STOCK PURCHASE WARRANT (the “Warrant”) certifies that, for value received, _____________ or its assigns (the “Holder”) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the date hereof (the “Initial Exercise Date”) and on or prior to 5:00 p.m. (New York City Time) on the Termination Date but not thereafter, to subscribe for and purchase from Cellectar Biosciences, Inc., a Delaware corporation (the “Company”), up to ______ shares (as subject to adjustment hereunder, the “Warrant Shares”) of Common Stock; provided however, that, in lieu of Warrant Shares, such Holder may elect to receive pre-funded common stock purchase warrants in lieu of some or all Warrant Shares in the form set forth on Exhibit C hereto (the “Pre-Funded Warrants”), if at the time of exercise, the Holder or its Affiliates would beneficially own in excess of the Beneficial Ownership Limitation (as defined below), in which
